The acquisition combines 2 family-owned fermentation and enzyme technology companies, adding manufacturing capacity.
The acquisition adds a leading, clinically studied muscle health brand and its patented Fortetropin® ingredient technology to PetIQ.
The deal will add biotechnology products and technical expertise to Innovad Group’s business in Brazil while supporting its plans across Latin America.
The new facility will bring together the company’s regional business functions and strengthen its pipeline of animal nutrition solutions across the region.
The project aims to reach 30,000 smallholder dairy farmers over a nine-month pilot period.
Major international companies, including Andritz Feed & Biofuel, Cargill, Charoen Pokphand Indonesia, Famsun, EW Nutrition, Elanco, Evonik, Olmix, ADM Protexin and Angel Yeast, showcased innovations.
The project is expected to be completed by mid-year 2027.
These new configurations provide greater storage capacity to suit different farm sizes, feeding systems and storage requirements.
The collaboration will introduce systematic blood biomarker analysis across the group’s production sites.
The facility will produce super-premium wet pet food for cats and dogs and will begin operations in 2029.